Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Mar 15, 2020; 12(3): 311-322
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.311
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.311
Table 2 Acute toxicity according to Common Terminology Criteria for Adverse Events 4.0, on patients receiving chemoradiotherapy, n (%)
| Toxicity | n = 82 | |
| Any Grade | Grade 3 or 4 | |
| Hematological toxicity | ||
| Neutropenia | 56 (68.3) | 16 (19.5) |
| Leukopenia | 59 (72.0) | 15 (18.3) |
| Febrile neutropenia | 3 (3.6) | 3 (3.6) |
| Thrombocytopenia | 11 (13.4) | 0 |
| Nonhematological toxicity | ||
| Diarrhea | 53 (64.6) | 22 (26.8) |
| Anorexia | 20 (24.4) | 1 (1.2) |
| Fatigue | 15 (18.3) | 0 |
| Nausea | 13 (15.9) | 0 |
- Citation: Kimura K, Beppu N, Doi H, Kataoka K, Yamano T, Uchino M, Ikeda M, Ikeuchi H, Tomita N. Impact of preoperative chemoradiotherapy using concurrent S-1 and CPT-11 on long-term clinical outcomes in locally advanced rectal cancer. World J Gastrointest Oncol 2020; 12(3): 311-322
- URL: https://www.wjgnet.com/1948-5204/full/v12/i3/311.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i3.311